Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

ERYTHROMYCIN ESTOLATE

All products: general benefit

Other products in the same Health Canada class (J01FA) — coverage varies; not interchangeable

  • Azithromycin (Zithromax): general benefit, Limited Use 549, Not a benefit
  • Clarithromycin (Biaxin XL): general benefit, Not a benefit
  • Erythromycin base (Erythromid): general benefit, Not a benefit
  • Erythromycin ethylsuccinate (Ees-200): general benefit, Not a benefit

Novo-Rythro Estolate · DIN 00262595 · 50mg/mL · oral liquid

General benefit; Health Canada lists this DIN as Cancelled post market since 2018-06-06 — choose a marketed DIN from the same-category list.Discontinued 2018-06-06 · checked 2026-09-19
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2018-06-06 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2018-06-06 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Novo-Rythro Estolate · DIN 00262595 Manufacturer: Novopharm Ltd.; listing date 1996-10-01 Daily cost (source): $1.4260 Health Canada: Cancelled post market since 2018-06-06 · brand NOVO-RYTHRO ESTOLATE SUSPENSION · ATC J01FA01 ERYTHROMYCIN · form Suspension · route Oral · ingredients ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) 250 MG/5ML · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Novo-Rythro Estolate: Formulary list price $0.0713/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0713 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1642 · Verify on the e-Formulary ↗ (DIN 00262595)

Source record
DIN 00262595: Novo-Rythro Estolate Raw flags: sec3=Y Item: 081212007; group id 23; item number 0038; lccId None; manufacturer id NOP Source form: O/L; strength: 50mg/mL Recorded listing: General benefit Source prices (unrounded): $0.0713; ministry $0.0713 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00262595 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1642
Interchangeable products
Ilosone · DIN 00210641 · not recorded
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since 2018-06-06 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (08:12:12 Erythromycins) and how they are covered

Matched class: 08:12:12 Erythromycins

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): AZITHROMYCIN, CLARITHROMYCIN, ERYTHROMYCIN BASE, ERYTHROMYCIN ETHYLSUCCINATE 08:12:12 Erythromycins

AZITHROMYCIN

· 28 products · Listed, not a benefit (6), General benefit (21), Limited Use, codes 549 (1) · strengths: 100mg/5mL, 200mg/5mL, 250mg, 600mg · O/L-15mL Pk, O/L-22.5mL Pk, O/L-37.5mL Pk, Tab

CLARITHROMYCIN

· 25 products · General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1), General benefit (15), Off-Formulary Interchangeable, not an ODB benefit (9) · strengths: 500mg, 125mg/5mL, 250mg/5mL, 250mg · ER Tab, Ped Gran, Susp, Tab

ERYTHROMYCIN BASE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 250mg · Tab

ERYTHROMYCIN ETHYLSUCCINATE

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 40mg/mL, 80mg/mL · O/L Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 08:12:12
Full class listing Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:16 Penicillins, 08:12:24 Tetracyclines, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no marketed product found